NCT02205502

Brief Summary

Ketamine seems an obvious choice in the setting of an emergency department in laceration repair. Lidocaine is the local anesthetics widespread used. Ketamine leads to dissociative amnesia. Theoretically , lidocaine is not useful in laceration repair using ketamine. However, lidocaine is used with ketamine in many emergency department. The investigators compare lidocaine with placebo as an adjunct to ketamine sedation in children undergoing primary closure

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
58

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Dec 2013

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 16, 2014

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 31, 2014

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

January 9, 2018

Status Verified

January 1, 2018

Enrollment Period

4.8 years

First QC Date

June 16, 2014

Last Update Submit

January 6, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Children's Hospital of Eastern Ontario Pain Scale (CHEOPS

    The investigators will measure pain scale of sedated children with the CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) during suturing of lacerated wound.

    up to 1 hour

Secondary Outcomes (3)

  • Sedation scale

    up to 1 hour

  • Complication

    up to 1 hour

  • Satisfaction of parents and clinicians

    up to 1 hour

Study Arms (2)

Lidocaine

EXPERIMENTAL

Proper amount of lidocaine will be injected lacerated wound. * dosage form: fluid * dosage: not exceeding 1mg/kg * frequency: once * duration: n/a

Drug: Lidocaine

Normal saline

PLACEBO COMPARATOR

Normal saline will be used as a placebo for lidocaine

Drug: Normal saline

Interventions

Normal saline will be injected subcutaneously as a placebo for lidocaine in study group of children.

Lidocaine
Normal saline

Eligibility Criteria

Age12 Months - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • patients who need suturing for laceration under procedural anesthesia using ketamine

You may not qualify if:

  • contraindication to ketamine and lidocaine
  • patients involved to other studies
  • more or equal to American Society of Anesthesiologist (ASA) class III
  • not alert

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 463-707, South Korea

RECRUITING

MeSH Terms

Conditions

Agnosia

Interventions

LidocaineSaline Solution

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAminesCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Jin Hee Lee, Professor

    Seoul National University Bundang Hospital

    PRINCIPAL INVESTIGATOR
  • Jin Hee Lee,, Professor

    Seoul National University Bundang Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jin Hee Lee, Professor

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 16, 2014

First Posted

July 31, 2014

Study Start

December 1, 2013

Primary Completion

October 1, 2018

Study Completion

October 1, 2018

Last Updated

January 9, 2018

Record last verified: 2018-01

Locations